# Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML

> **NCT03537560** · — · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 334 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03537560
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2023-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537560, "Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03537560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*